维普期刊资源整合服务平台（V6.5）

43篇 您的检索式：作者名="ROOBOL MJ"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Prostate cancer mortality reduction by prostate-specific antigen based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)显示文摘	ROOBOL MJ KERKHOF M SCHRODER FH		0，，：	1
2	The effect of study arm on prostate cancer treatment in the large screening trial ERSPC显示文摘	WOLTERS T ROOBOL MJ STEVERBERG EW		0，，：	1
3	Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program显示文摘	Raaijmakers R Kirkels WJ Roobol MJ	2002	Urolo- gy2002，60，5：	1
4	Screen- ing and prostate -cancer mortality in a randomized European study显示文摘	Schrfider FH Hugosson J Roobol MJ	2009	N Engl J Med2009，360，13：	1
5	A riskbased strategy improves prostate-specific antigen-driven detection of prostate cancer显示文摘	ROOBOL MJ STEYERBERG EW KRANSE R		0，，：	1
6	Risk stratification in prostate cancer screening显示文摘	ROOBOL MJ CARLSSON SV		0，，：	1
7	Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer-related or all-cause mortality but results likely due to heterogeneity-the two highest quality studies identified do find prostate cancer-related mortality reductions 显示文摘	Roobol MJ Carlsson S Hugosson J	2011	Evid Based Med2011，16，：	1
8	Screening and prostate-cancer mortality in a randomized European study显示文摘	Schroder FH Hugosson J Roobol MJ	2009	N Engl J Med2009，360，13：	1
9	Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer(ERSPC)显示文摘	Roobol MJ Kerkhof M Schroder FH	2009	Eur Urol2009，56，4：	1
10	Magnetic resonanceimaging-targeted biopsy may enhance the diagnostic accuracy ofsignificant prostate cancer detection compared to standardtransrectal ultrasound-guided biopsy : a systematic review andMeta-analysis显示文摘	Schoots IG Roobol MJ Nieboer D	2015	Eur Urol2015，68，：	1
11	Prostate specific antigen velocity at low Prostate specific antigen levels as screening tool for prostate cancer: results of seconds screening round of RSPC (ROTTEREAM) 显示文摘	ROOBOL MJ KRANSE R DE KONING HJ	2004	Urology2004，63，2：	1
12	Prostate - cancer mortality at 11 years of follow - up 显示文摘	Schrder FH Hugosson J Roobol MJ	2012	New England Journal of Medicine2012，366，11：	1
13	Screening and prostate-cancer mortality in a randomized European study显示文摘	Schroder FH Hugosson J Roobol MJ	2009	N Engl J Med2009，360，13：	1
14	Outcomes ofmen with screen-detected prostate cancer eligible for active surveil-lance who were managed expectantly 显示文摘	Van den Bergh RC Roemeling S Roobol MJ	2009	Eur Urol2009，55，1：	1
15	Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European randomized study of screening for prostate cancer (rouerdam) 显示文摘	Wolters T Roobol MJ Bangma CH	2009	Eur Urol2009，55，2：	1
16	Screening and prostate-cancer mortality in a randomized European study显示文摘	Schrder FH Hugosson J Roobol MJ	2009	N Engl J Med2009，360，13：	1
17	Defining the optimal prostate- specific antigen threshold for the diagnosis of prostate cancer显示文摘	Schroder FH Roobol MJ	2009	Curt Opin Urol2009，19，3：	1
18	Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)显示文摘	Roobol MJ Kerkhof M Schroder FH	2009	Eur Urol2009，56，4：	1
19	Screening for prostate cancer: early detection or overdeteetion 显示文摘	Vickers AJ Roobol MJ Lilja H	2012	Annual review of medicine2012，63，：	1
20	Screening and prostate-cancer mortality in a randomized European study显示文摘	Schroder FH Hugosson J Roobol MJ		0，，13：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示